Viridian Therapeutics, Inc. (VRDN)
16.11
+0.38
(+2.42%)
USD |
NASDAQ |
Jun 09, 14:39
Viridian Therapeutics SG&A Expense (Quarterly) : 38.68M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.602B |
| Spyre Therapeutics, Inc. | 15.23M |
| Praxis Precision Medicines, Inc. | 27.87M |
| CAMP4 Therapeutics Corp. | 4.205M |
| Savara, Inc. | 15.57M |